Structural, mechanistic and physiological insights into phospholipase A-mediated membrane phospholipid degradation in Pseudomonas aeruginosa

  1. Florian Bleffert
  2. Joachim Granzin
  3. Muttalip Caliskan
  4. Stephan N Schott-Verdugo
  5. Meike Siebers
  6. Björn Thiele
  7. Laurence G Rahme
  8. Sebastian Felgner
  9. Peter Dörmann
  10. Holger Gohlke  Is a corresponding author
  11. Renu Batra-Safferling  Is a corresponding author
  12. Karl Erich-Jäger
  13. Filip Kovacic  Is a corresponding author
  1. Heinrich Heine University Düsseldorf, Germany
  2. Forschungszentrum Jülich GmbH, Germany
  3. University of Bonn, Germany
  4. Harvard Medical School, United States
  5. Helmholtz Centre for Infection Research, Germany

Abstract

Cells steadily adapt their membrane glycerophospholipid (GPL) composition to changing environmental and developmental conditions. While the regulation of membrane homeostasis via GPL synthesis in bacteria has been studied in detail, the mechanisms underlying the controlled degradation of endogenous GPLs remain unknown. Thus far, the function of intracellular phospholipases A (PLAs) in GPL remodeling (Lands cycle) in bacteria is not clearly established. Here, we identified the first cytoplasmic membrane-bound phospholipase A1 (PlaF) from Pseudomonas aeruginosa, which might be involved in the Lands cycle. PlaF is an important virulence factor, as the P. aeruginosa ΔplaF mutant showed strongly attenuated virulence in Galleria mellonella and macrophages. We present a 2.0-Å-resolution crystal structure of PlaF, the first structure that reveals homodimerization of a single-pass transmembrane (TM) full-length protein. PlaF dimerization, mediated solely through the intermolecular interactions of TM and juxtamembrane regions, inhibits its activity. The dimerization site and the catalytic sites are linked by an intricate ligand-mediated interaction network, which might explain the product (fatty acid) feedback inhibition observed with the purified PlaF protein. We used molecular dynamics simulations and configurational free energy computations to suggest a model of PlaF activation through a coupled monomerization and tilting of the monomer in the membrane, which constrains the active site cavity into contact with the GPL substrates. Thus, these data show the importance of the PlaF mediated GPL remodeling pathway for virulence and could pave the way for the development of novel therapeutics targeting PlaF.

Data availability

Diffraction data have been deposited in PDB under the accession code 6I8W.All data generated or analysed during this study are included in the manuscript and supporting file.Sequencing data are embedded in Fig. S1b.Source Data file "Table S1 - lipidome" has been provided for Figure 2. It contains the numerical data used to generate the figure 2c.Source data used to calculate the potentials of mean force and their corresponding simulation trajectory files shown in figure 7 and figure 7-supplementary figure 1 are accessible at the DSpace instance researchdata.hhu.de under DOI: 10.25838/d5p-31.

The following data sets were generated

Article and author information

Author details

  1. Florian Bleffert

    Institute of Molecular Enzyme Technology, Heinrich Heine University Düsseldorf, Duesseldorf, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Joachim Granzin

    Forschungszentrum Jülich GmbH, Jülich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Muttalip Caliskan

    Institute of Molecular Enzyme Technology, Heinrich Heine University Düsseldorf, Duesseldorf, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Stephan N Schott-Verdugo

    Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University Düsseldorf, Duesseldorf, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Meike Siebers

    Institute of Molecular Physiology and Biotechnology of Plants, University of Bonn, Bonn, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Björn Thiele

    Forschungszentrum Jülich GmbH, Jülich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Laurence G Rahme

    Department of Microbiology and Immunobiology, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5374-4332
  8. Sebastian Felgner

    Department of Molecular Bacteriology, Helmholtz Centre for Infection Research, Braunschweig, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0030-2490
  9. Peter Dörmann

    Institute of Molecular Physiology and Biotechnology of Plants, University of Bonn, Bonn, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5845-9370
  10. Holger Gohlke

    Heinrich Heine University Düsseldorf, Dusseldorf, Germany
    For correspondence
    gohlke@uni-duesseldorf.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8613-1447
  11. Renu Batra-Safferling

    Forschungszentrum Jülich GmbH, Jülich, Germany
    For correspondence
    r.batra-safferling@fz-juelich.de
    Competing interests
    The authors declare that no competing interests exist.
  12. Karl Erich-Jäger

    Institute of Molecular Enzyme Technology, Heinrich Heine University Düsseldorf, Duesseldorf, Germany
    Competing interests
    The authors declare that no competing interests exist.
  13. Filip Kovacic

    Institute of Molecular Enzyme Technology, Heinrich Heine University Düsseldorf, Duesseldorf, Germany
    For correspondence
    f.kovacic@fz-juelich.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0313-427X

Funding

Deutsche Forschungsgemeinschaft (267205415)

  • Holger Gohlke
  • Karl Erich-Jäger
  • Filip Kovacic

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Arun Radhakrishnan, University of Texas Southwestern Medical Center, United States

Version history

  1. Preprint posted: June 23, 2021 (view preprint)
  2. Received: August 5, 2021
  3. Accepted: May 10, 2022
  4. Accepted Manuscript published: May 10, 2022 (version 1)
  5. Version of Record published: May 25, 2022 (version 2)

Copyright

© 2022, Bleffert et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,061
    Page views
  • 363
    Downloads
  • 6
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Florian Bleffert
  2. Joachim Granzin
  3. Muttalip Caliskan
  4. Stephan N Schott-Verdugo
  5. Meike Siebers
  6. Björn Thiele
  7. Laurence G Rahme
  8. Sebastian Felgner
  9. Peter Dörmann
  10. Holger Gohlke
  11. Renu Batra-Safferling
  12. Karl Erich-Jäger
  13. Filip Kovacic
(2022)
Structural, mechanistic and physiological insights into phospholipase A-mediated membrane phospholipid degradation in Pseudomonas aeruginosa
eLife 11:e72824.
https://doi.org/10.7554/eLife.72824

Share this article

https://doi.org/10.7554/eLife.72824

Further reading

    1. Biochemistry and Chemical Biology
    2. Medicine
    Giulia Leanza, Francesca Cannata ... Nicola Napoli
    Research Article

    Type 2 diabetes (T2D) is associated with higher fracture risk, despite normal or high bone mineral density. We reported that bone formation genes (SOST and RUNX2) and advanced glycation end-products (AGEs) were impaired in T2D. We investigated Wnt signaling regulation and its association with AGEs accumulation and bone strength in T2D from bone tissue of 15 T2D and 21 non-diabetic postmenopausal women undergoing hip arthroplasty. Bone histomorphometry revealed a trend of low mineralized volume in T2D (T2D 0.249% [0.156–0.366]) vs non-diabetic subjects 0.352% [0.269–0.454]; p=0.053, as well as reduced bone strength (T2D 21.60 MPa [13.46–30.10] vs non-diabetic subjects 76.24 MPa [26.81–132.9]; p=0.002). We also showed that gene expression of Wnt agonists LEF-1 (p=0.0136) and WNT10B (p=0.0302) were lower in T2D. Conversely, gene expression of WNT5A (p=0.0232), SOST (p<0.0001), and GSK3B (p=0.0456) were higher, while collagen (COL1A1) was lower in T2D (p=0.0482). AGEs content was associated with SOST and WNT5A (r=0.9231, p<0.0001; r=0.6751, p=0.0322), but inversely correlated with LEF-1 and COL1A1 (r=–0.7500, p=0.0255; r=–0.9762, p=0.0004). SOST was associated with glycemic control and disease duration (r=0.4846, p=0.0043; r=0.7107, p=0.00174), whereas WNT5A and GSK3B were only correlated with glycemic control (r=0.5589, p=0.0037; r=0.4901, p=0.0051). Finally, Young’s modulus was negatively correlated with SOST (r=−0.5675, p=0.0011), AXIN2 (r=−0.5523, p=0.0042), and SFRP5 (r=−0.4442, p=0.0437), while positively correlated with LEF-1 (r=0.4116, p=0.0295) and WNT10B (r=0.6697, p=0.0001). These findings suggest that Wnt signaling and AGEs could be the main determinants of bone fragility in T2D.

    1. Biochemistry and Chemical Biology
    Valentin Bohl, Nele Merret Hollmann ... Axel Mogk
    Research Article

    Heat stress can cause cell death by triggering the aggregation of essential proteins. In bacteria, aggregated proteins are rescued by the canonical Hsp70/AAA+ (ClpB) bi-chaperone disaggregase. Man-made, severe stress conditions applied during, e.g., food processing represent a novel threat for bacteria by exceeding the capacity of the Hsp70/ClpB system. Here, we report on the potent autonomous AAA+ disaggregase ClpL from Listeria monocytogenes that provides enhanced heat resistance to the food-borne pathogen enabling persistence in adverse environments. ClpL shows increased thermal stability and enhanced disaggregation power compared to Hsp70/ClpB, enabling it to withstand severe heat stress and to solubilize tight aggregates. ClpL binds to protein aggregates via aromatic residues present in its N-terminal domain (NTD) that adopts a partially folded and dynamic conformation. Target specificity is achieved by simultaneous interactions of multiple NTDs with the aggregate surface. ClpL shows remarkable structural plasticity by forming diverse higher assembly states through interacting ClpL rings. NTDs become largely sequestered upon ClpL ring interactions. Stabilizing ring assemblies by engineered disulfide bonds strongly reduces disaggregation activity, suggesting that they represent storage states.